Successful application of our discovery antibody microarrays in a study on bladder cancer:

In the study more than 100 biomarker candidates were identified for a prognosis of recurrence in non-muscle invasive bladder cancer. A  multivariate classifier was constructed that is based on the expression variation of 20 proteins and facilitates the prediction of recurrence with a sensitivity of 80% at a specificity of 100%.

Further informations: